Countries World
The new project, supported by the European Union’s PharmaNext Programme, focuses on population-specific molecular profiling and AI-driven precision m...
January 28, 2026 | News
WuXi Biologics (2269.HK), a global leading Contract Research, Development and Manufacturing Organization (CRDMO), and HanchorBio Inc. (TPEx: 7827), a globa...
January 27, 2026 | News
Blau Farmacêutica, a Brazilian pharmaceutical company listed on Brazilian Stock Market (B3) and a regional leader in hospital pharmaceuticals w...
January 27, 2026 | News
Imagine Devices Inc., a medical device company focused on advancing neonatal and pediatric critical care, announced a strategic partnership with Neotech Pr...
January 27, 2026 | News
Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that the first patient has been dosed...
January 26, 2026 | News
Investigational New Drug (IND) approval from the U.S. Food and Drug Administration (FDA) paves the way for ISM8969 clinical study in the United Stat...
January 26, 2026 | News
Series D1 financing with participation from a syndicate of global healthcare-focused investors, including RTW Investments, SR One Capital Management (SR ...
January 26, 2026 | News
SK bioscience announced that it is advancing the development of a Zaire ebolavirus vaccine under a new collaboration supported by the Coalition for Epidemi...
January 23, 2026 | News
Investment in Canadian headquarters fuels expansion of Canadian operations, advancing access to innovative cancer medicines Daiichi Sankyo (TSE: 4568)...
January 23, 2026 | News
Alcami Corporation, a leading U.S.-based contract development and manufacturing organization (CDMO), has acquired a 37,000-square-foot facility at 4620 Cre...
January 21, 2026 | News
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") announces that the first patient in the United States (U.S.) has been dosed in BiPASS&...
January 20, 2026 | News
- UCSD's Dr. Davey Smith, former ACTIV-2 Protocol Chair, endorses 'Xafty' as "The weapon to end the virus war." - Announces "One Drug, Two Tracks...
January 19, 2026 | News
Total of 945 integrated projects in 2025, including 74 Phase III clinical projects and 25 commercial manufacturing projects 209 new integrated projects ...
January 19, 2026 | News
GCCL, a leading South Korea-based provider of clinical trial sample analysis, and OPIS, a global full-service contract research organization (CR...
January 19, 2026 | News
Most Read
Bio Jobs
News
Editor Picks